OOS Results - Very helpful Q&As published on the MHRA Website
![Stability Studies to Support Shipping/Distribution of Pharmaceuticals and Biopharmaceuticals - Live Online Training](files/eca/userImages/training.img/Z-ECA-Stability-Studies-Shipping-Distribution-LOT.jpg)
Recommendation
12/13 September 2024
The FDA Guidance on OOS Results from 2006 is well known among the pharmaceutical industry. Guidance from the MHRA on how to handle out-of-specification results during laboratory analysis is - on the contrary - pretty unknown although an own webpage on the MHRA website is dedicated to the OOS topic.
This webpage lists 20 questions. Here are some of the topics dealt with:
- When is it acceptable to declare test results invalid?
- How many repeat tests should be conducted?
- Can OOS results and pass results be combined?
- How the certifying QP should handle unclear results
- Averaging of separate test results
- Retesting
- Re-sampling
- Outlier tests
To read all the 20 questions and answers please see "Out of specification (OOS) FAQs".
On the MHRA website, you can find a complete presentation on Out Of Specification Investigations. The presentation ends with the following statement: "Microbiological expectations will be provided at a later date."
At ECA's OOS Forum on 19/20 June 2012 in Prague, Di Morris, GMP Inspector for Medicines and Healthcare products, MHRA, UK, will give a presentation about "OOS in Microbiology". For the first time ever, she will present the requirements of a European authority regarding the GMP-compliant handling of OOS results in the microbiological laboratory.
Author:
Dr Günter Brendelberger
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
24.07.2024FDA Warning Letter to Chinese OTC Manufacturer for Lack of Analytical Test Data
10.07.2024Pharmeuropa: Two Revised Chapters on Dissolution Testing published for comments
03.07.2024FDA Warning Letter: GMP Requirements also apply to HPLC Analyses for Internal Use
12.06.2024NMPA Announcement on Application of ICH Q2(R2) and Q14 Principles
22.05.2024Q&As from the Live Online Training "Introduction to the AQCG's new AIQSV Guide" - Part 1
22.05.2024FDA Warning Letter to Contract Testing Laboratory in Uruguay due to Data Integrity Violations